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Protein aggregation is a feature of both normal cellular
assemblies and pathological protein depositions. Al-
though the limited order of aggregates has often im-
peded their structural characterization, 3D domain
swapping has been implicated in the formation of sev-
eral protein aggregates. Here, we review known struc-
tures displaying 3D domain swapping in the context
of amyloid and related fibrils, prion proteins, and mac-
roscopic aggregates, and we discuss the possible
involvement of domain swapping in protein deposition
diseases.
Introduction
Deposition diseases are characterized by aggregation
of proteins encoded by the afflicted individual’s own ge-
nome. The soluble proteins associated with such dis-
eases often perform well-characterized and essential
biological functions under normal circumstances. How-
ever, in the disease state, provoked by a change in envi-
ronment or genetic predisposition, some part of the
native fold is lost, thus exposing a template for the growth
of aggregates. The importance of this conformational
change in triggering aggregation has led to the term
conformational disease to describe these disorders.
From the structural biologist’s point of view, it is helpful
to divide deposition diseases into two broad categories
distinguished by whether or not the deposited aggre-
gates have the properties of amyloid fibrils. Amyloid
fibrils are typically composed of two or more protofila-
ments, each with a central spine of b strands running per-
pendicular to the fibril axis (cross-b spine), as evidenced
by the ability of fibrils to orient the dye Congo red
(producing birefringence under polarized light) and by
the appearance of a cross-b diffraction pattern. Extracel-
lular deposition of these fibrils is found in w25 well-
defined clinical syndromes called amyloidoses, each
associated with a characteristic protein or peptide that
constitutes the fibril (Pepys, 2006; Sipe and Cohen,
2000; Westermark et al., 2005) (green circle in Figure 1).
Several amyloid diseases, such as Alzheimer’s and type
II diabetes, are associated with the deposition of amyloid
fibrils but have not been proven to be caused by such
deposits (Pepys, 2006).
Other diseases differ from the amyloidoses in that
the associated fibrils are intracellular (e.g., huntingtin,
a-synuclein), and, in some cases, fibrils are not associ-
ated with human disease (e.g., Sup35 fibrils associated
*Correspondence: david@mbi.ucla.eduwith the [PSI+] phenotype in yeast). Such fibrils are re-
ferred to as ‘‘amyloid-like.’’ Also, in many laboratories,
researchers infer the structure of amyloid by studying
amyloid-like fibrils that can be formed from a variety of
proteins in vitro. Thus, amyloid-like fibrils differ from
classical amyloid in that they are not extracellular, dis-
ease-associated deposits. Nevertheless, at a fundamen-
tal level, amyloid-like fibrils share many of the same bio-
physical characteristics of amyloid fibrils, for example,
the presence of cross-b spines.
The second category of deposition disorders includes
‘‘nonamyloid’’ fibrils or aggregates, which lack cross-
b spines. In sickle cell anemia (Hemoglobin S [HbS];
pink circle in Figure 1) and the serpinopathies (a1-anti-
trypsin and neuroserpin; orange circle), the nonamyloid
fibrils that are formed retain native structures. In other
diseases, the nonamyloid fibrils and aggregates have
yet to be characterized in detail (blue box in Figure 1). A
deepened understanding of the underlying mechanisms
of protein aggregation is crucial for the development of
diagnostics and therapeutics for deposition diseases,
which are so devastating to affected individuals and so
costly to society. Here, we consider 3D domain swap-
ping as a mechanism for forming some of the fibrils
and aggregates that occur in deposition diseases.
Mechanisms for Forming Protein Fibrils
and Other Deposits
In general, what are the mechanisms that account for the
specific self-association of proteins? Structural data so
far suggest that there are three possible mechanisms:
cross-b spine, end-to-end stacking, and 3D domain
swapping. Figure 1 shows a Venn diagram that classifies
a number of proteins involved in deposition diseases,
cellular assemblies, or in vitro aggregates according to
their mechanisms of association. As shown by the pro-
teins in overlapping areas, in some cases more than
one mechanism may be operative. We consider these
mechanisms separately as follows.
The cross-b spine mechanism of association has his-
torically been inferred from the cross-b diffraction pat-
tern observed for most classical, disease-associated
amyloid fibrils and a number of amyloid-like fibrils that
occur in vitro (green circle in Figure 1). Amyloid and
amyloid-like fibrils appear in electron microscopy as
rigid, nonbranching ultrastructures that are of varying
length, are w60–130 A˚ in diameter, bind Congo red,
and display ‘‘apple-green’’ birefringence under polarized
light (Sipe and Cohen, 2000; Westermark et al., 2005).
Amyloid-like fibrils can be formed in vitro from a variety
of proteins with all classes of secondary structure (e.g.,
RNase A Q10 mutant [Sambashivan et al., 2005] or myo-
globin [Fandrich et al., 2003]). It has been suggested
that virtually any protein can form amyloid-like fibrils
under appropriate conditions (Chiti et al., 1999). Despite
the diversity of structures in the native state, in the fibril-
lar state the proteins convert at least partially to stacked
b sheets with main chain hydrogen bonds parallel to the
fibril axis and side chains perpendicular to the fibril axis,
as inferred from the w4.7 A˚ meridional and 10 A˚
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812Figure 1. Higher-Order Protein Assemblies in Health and Disease
A Venn diagram showing the structural mechanisms by which proteins form filaments, fibrils, or aggregates in cellular assemblies, human
diseases, and model systems in vitro. Proteins that form amyloid or amyloid-like fibrils, as defined by the presence of a cross-b spine (Sunde
et al., 1997), are shown in the green circle. Amyloid fibrils are those that (1) are associated with disease, (2) are extracellular in localization, and
(3) display Congo red binding and birefringence (Pepys, 2006; Sipe and Cohen, 2000; Westermark et al., 2005). Some amyloid fibrils have been
suggested to form by pathways involving 3D domain swapping (e.g., cystatin C [Nilsson et al., 2004; Sanders et al., 2004] and b2-microglobulin
[Eakin et al., 2004]). Fibrils formed from some proteins, such as SOD, are believed to involve stacking of subunits that contain native-like b sheets
(Elam et al., 2003). Some amyloid-like fibrils have an intracellular localization or differ from amyloid in tinctorial properties (e.g., in Huntington’s or
Parkinson’s disease). Other amyloid-like fibrils include those that are not associated with deposition diseases in vivo, such as fibrils derived from
model protein or peptide systems in vitro (e.g., myoglobin [Fandrich et al., 2003], RNase A Q10 [Sambashivan et al., 2005], PRP
RDX [Lee and Eisen-
berg, 2003], GNNQQNY [Nelson et al., 2005], and AAAK [actual sequence KFFEAAAKKFFE] peptides [Makin et al., 2005]). Other proteins not as-
sociated with deposition disease include the cytoskeletal proteins actin (Holmes et al., 1990) and tubulin (Downing and Nogales, 1999), shown in
the pink circle, as well as GB1 (Louis et al., 2005), RecA (Story et al., 1992; Xing and Bell, 2004), DS-Ag (Ogihara et al., 2001), T7 helicase (Sawaya
et al., 1999), ‘‘cab’’-type carbonic anhydrase (Strop et al., 2001), and the trpR entirely domain-swapped crystal (Lawson et al., 2004). The blue box
lists some examples of disease deposits for which there is insufficient structural information for classification into the Venn diagram. Note that
some disease-associated fibrils lack a cross-b spine (e.g., Hemoglobin S [Dykes et al., 1978; Wishner et al., 1975]; serpins, reviewed in [Lomas
and Carrell, 2002]; and nonamyloid fibrils identified histopathologically [negative Congo red binding assays; blue box]).equatorial reflections in fiber diffraction (Blake and Ser-
pell, 1996; Sunde et al., 1997).
Details of the cross-b spine have recently been re-
vealed by atomic resolution single-crystal X-ray diffrac-
tion studies of the peptide GNNQQNY from the prion-
determining domain of Sup35 (Nelson et al., 2005). The
structure shows that the cross-b spine is comprised of
a pair of b sheets and reveals that strands within each
sheet interact through conventional backbone hydrogen
bonds as well as hydrogen bonds between glutamineand asparagine side chains. Two sheets interact
through a ‘‘steric zipper’’ in which dehydrated side
chains are tightly enmeshed (Nelson et al., 2005). Thus,
the steric zipper is the molecular interaction that binds
the two sheets in a cross-b spine. The cross-b spine is
a form of self-complementation that can be combined
with domain swapping (e.g., hinge loop of RNase A Q10
[Sambashivan et al., 2005]). Inasmuch as one considers
a ‘‘minimal’’ cross-b motif to exist (i.e., a pair of zipped
strands), the cross-b spine in peptide structures can
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813be said to involve end-to-end stacking as well (e.g.,
GNNQQNY and other peptides [Makin et al., 2005;
Nelson et al., 2005]).
Native proteins that stack like building blocks but do
not form cross-b spines are familiar examples of aggre-
gation through end-to-end stacks (pink circle) (e.g.,
HbS or cytoskeletal proteins). The lack of a cross-b spine
does not preclude involvement in serious disease: sickle
cell anemia involves fibrils of HbS that impair red blood
cell function. Fibrils of HbS resemble amyloid fibrils (al-
though they are somewhat larger, at 210 A˚ diameter),
and they display optical birefringence of a bound chro-
mophore (heme) (reminiscent of the birefringence of
Congo red bound to amyloid fibrils) and provide evi-
dence that native-like aggregated structures can yield
highly ordered fibrils in deposition diseases. This sup-
ports the idea that native-like structures can be involved
in disease fibril formation, which would also occur in
3D domain swapping. Other proteins involved in normal
cellular processes (e.g., cellular assemblies in pink circle
in Figure 1) also form higher-order structures by end-to-
end stacks.
Stacking of proteins in an end-to-end manner has been
suggested to produce a cross-bdiffraction pattern if it oc-
curs in a protein containing native b sheets. Transthyretin
(TTR) (Correia et al., 2006; Serag et al., 2002), superoxide
dismutase (SOD) (Elam et al., 2003), cystatin C (Janowski
et al., 2005), and GB1 (Louis et al., 2005) form fibrils that
have been suggested to contain native-like structures
comprised of b sheets or b sandwiches. Though such
structures would not contain cross-b spines, a cross-b
diffraction pattern could result if b strands were fortu-
itously oriented perpendicular to the fiber axis.
3D Domain Swapping: Beyond Small Oligomers
3D domain swapping is a third mechanism for aggrega-
tion of proteins, and it is the mechanism that we shall
focus on in this review. Domainswapping is amechanism
for forming homodimers and higher-order oligomers by
the exchange of protein domains. The ‘‘swapped’’ do-
main can be an element of secondary structure or a glob-
ular protein domain, and it is linked to the ‘‘core’’ of the
protein by a ‘‘hinge loop’’ (Figure 2A). In the simplest
example, homodimerization, domain swapping takes
place when a pair of ‘‘closed monomers’’ (Figure 2A)
opens to form a pair of ‘‘open monomers’’ by rotating
about the hinge loop. Domains are then exchanged be-
tween protomers, reconstituting two ‘‘functional units’’
(FU), each comprised of residues from two protein
chains. The preservation of the FU in domain-swapped
dimers was first elegantly elucidated in complementa-
tion studies of inactivated RNase A molecules, which re-
constitute activity after domain swapping (Crestfield
et al., 1962). Such a swap is referred to as being closed
ended, because the swap is reciprocal; there are no un-
satisfied (exposed) domains (as in the dimer schematic
shown in Figure 2A, bottom right). However, open-ended
‘‘runaway’’ domain swaps, in which domain-swapped
oligomers propagate (as a protofilament) with at least
one unsatisfied domain at each terminus (as in the
filament shown in Figure 2A, top right), also occur.
There are two features of domain swapping that impli-
cate it as a mechanism for linking protomers into oligo-
mers, aggregates, or fibrils such as those involved indeposition diseases (Figure 2A). First, domain swapping
is compatible with a diverse set of proteins such as those
involved in deposition diseases. It does not require
a specific sequence since the formation of this type of
intermolecular interface is primarily a matter of self-com-
plementation. That is, the domain-swapped dimer or
higher oligomer is stabilized by the same interdomain in-
teractions that are found in the closed monomer (red in
Figure 2A). Only the hinge loop changes significantly in
conformation upon domain swapping. Many examples
of domain swapping have been observed by crystallo-
graphy and NMR. These include more than 30 closed-
ended small oligomers, but also a few open-ended run-
away swaps (Liu and Eisenberg, 2002). Human prion
protein (Figure 2B) and cystatin C (Figure 2C) are two
examples of proteins that are domain swapped and are
also known to be involved in amyloid or prion disease
(Janowski et al., 2001; Knaus et al., 2001; Prusiner,
1998). The hinge loops form a small b sheet in each.
The second feature of domain swapping that impli-
cates it in deposition diseases is the strength of the
bond that it forms between protomers. Amyloid deposits
are characteristically resistant to proteolysis. This tight
enmeshing of proteins might partially explain how the
proteins are able to evade the cell’s protein degradation
machinery. Domain swapping creates a strong, flexible
tether. In effect, the entire intramolecular interface in
the monomeric protein forms an intermolecular contact
in the oligomer. The result is the production of unusually
large interfaces due to numerous protein-protein inter-
actions that evolved in the closed monomer.
Several biochemical studies have implicated domain
swapping in the formation of fibrils from proteins in-
volved in conformational diseases, such as hamster
prion protein PrPRDX (Lee and Eisenberg, 2003), cystatin
C (Jaskolski, 2001; Nilsson et al., 2004; Sanders et al.,
2004), and b2-microglobulin (Eakin et al., 2004). The
DS-Ag designer peptide also forms fibrils by domain
swapping. DS-Ag fibrils retain their nativea-helical struc-
ture within fibrils (Ogihara et al., 2001) and provide an
example of domain swapping in a nonamyloid fibril.
Structural studies have also uncovered potential roles
for domain swapping in the architecture of oligomers, fi-
bers, and other aggregates. The structures reviewed
here demonstrate that domain swapping can lead to
higher-order aggregates in diverse ways, some of which
may be relevant both for cellular assemblies and deposi-
tion diseases.
Evidence for Runaway Swaps: Infinite Linear
Filaments in Crystal Structures
Infinite linear filaments have been observed in several
crystals, lending support for the open-ended runaway
swap model (Figure 2A). Such structures provide
a means of observing filamentous assemblies that would
otherwise be intractable by single-crystal diffraction or
NMR methods. In these structures, domain exchange
occurs between molecules related by screw-axis sym-
metry within crystals. These include T7 helicase (Fig-
ure 3A) (Sawaya et al., 1999) and RecA (Story et al.,
1992; Xing and Bell, 2004), which have 61 screw axes,
and also include a1-antitrypsin (Huntington et al., 1999)
(Figure 3B) and ‘‘cab’’-type carbonic anhydrase (Strop
et al., 2001), which have 21 screw axes. Two of these
Structure
814Figure 2. Introduction to 3D Domain Swap-
ping and Examples of Closed Homodimers
in Amyloid and Prion Proteins
(A) Structures involved in 3D domain swap-
ping. A closed monomer is a single protein
chain folded into two (or more) domains
(square or semicircle) with an interdomain in-
terface between them (red). Domains are
connected by a flexible hinge loop. Open
monomers formed by mutation or changes
in environmental conditions can be con-
verted to domain-swapped dimers or higher
oligomers. In the domain-swapped struc-
tures, the interdomain interface is reformed.
Domain swapping can be ‘‘closed-ended,’’
with all domains satisfied (as in the dimer),
or ‘‘open-ended,’’ with unsatisfied domains.
The functional unit (FU) is shown in the green
dashed box and is comprised of domains
from different polypeptide chains. In this ex-
ample, the FU is essentially identical to the
structure of the closed monomer, with the
exception of the hinge loop. The hinge loop
is the only segment of the structure that
changes conformation significantly upon 3D
domain swapping.
(B) Monomeric (Zahn et al., 2000) and dimeric
(Knaus et al., 2001) human prion protein
(PrPC; residues 90–231). The hinge loops in
dimeric PrPC form a small antiparallel b sheet
with six main chain hydrogen bonds, as well
as a short helix.
(C) Monomeric chicken cystatin (Bode et al.,
1988) and dimeric human cystatin C (Janow-
ski et al., 2001). The hinge loops in dimeric
cystatin form an antiparallel b sheet. Mutants
of cystatin C form amyloid deposits in a he-
reditary hemorrhagic stroke disorder. Ribbon
diagrams were made with PyMOL (DeLano,
2006).proteins are also known to form polymers in solution
(RecA and a1-antitrypsin). Domain-swapped filaments
of the type illustrated by these examples would not in-
clude the cross-b spines required for amyloid or amy-
loid-like fibrils. However, as shown by the example of
HbS, a cross-b spine is not essential for producing large
fibers that may be involved in disease. In addition, do-
main swapping can be combined with a cross-b spine
as seen in RNase A (discussed below).
To qualify as domain swaps, the interface in the open-
ended oligomer must be identical to the interface in
the closed reference molecule. This and the following
paragraph show how four crystalline arrays qualify as
runaway domain swaps. We consider T7 helicase and
a1-antitrypsin filaments to be quasi domain swaps, be-
cause each has a structurally characterized ‘‘closed’’
counterpart that is very close in sequence to the protein
that forms the open-ended filament. The closed counter-
part of the 4E fragment of T7 helicase is the 4D fragment
hexamer, which differs by having a 30 residue N-terminal
extension (Figure 3A, left), and the closed counterpart of
the Pittsburgh variant of a1-antitrypsin (M358R) is the
S variant closed monomer (E264V) (Figure 3B, left).Note that the closed reference state can include closed
oligomers in addition to closed monomers, as depicted
in Figure 2A. In each of the filaments in Figure 3 (right
panel), the intersubunit interface that binds the filament
together is an interface that is also present in the closed
reference molecule.
The other examples of domain-swapped filaments,
those formed by M. thermoautotrophicum ‘‘cab’’-type
carbonic anhydrase and E. coli RecA, are likely to be
bona fide swaps, although the closed reference states
of the identical proteins have not been structurally char-
acterized at atomic resolution. In solution, M. thermoau-
totrophicum ‘‘cab’’-type carbonic anhydrase is a tetramer
that is expected to be similar to dimers and octomers of
b-type carbonic anhydrases from other organisms (Strop
et al., 2001; Suarez Covarrubias et al., 2005). In addition to
the filaments that have been widely studied, E. coli RecA
forms a closed ring, which is presumably similar to that
characterized in a different organism by electron micros-
copy (Yu and Egelman, 1997).
The example of the T7 helicase 4E fragment from
E. coli (Figure 3A) illustrates the general features of an
open-ended runaway swap. The assembly of the T7
Review
815Figure 3. Domain-Swapped Filaments in Crystals
Infinite linear filaments are formed in which each subunit is related to the next by a crystallographic screw-axis (a 21 axis for a1-antitrypsin; a 61
axis for T7 helicase). Each subunit (a covalent polypeptide chain in T7 helicase, and a cleaved polypeptide chain in a1-antitrypsin) is identified by
a unique color. The closed monomer or small oligomer (e.g., hexamer for T7 helicase) is shown on the left. The open dimer is defined as a structure
containing a single FU (indicated by a black box) and open ends that can potentially interact with other subunits (middle). In the infinite linear
filament (right), the open dimer is highlighted in colored ribbons and the unit cell is indicated as a red box.
(A) The T7 helicase 4D fragment (residues 241–566) is an intertwined hexamer (left) (Singleton et al., 2000). The FU highlighted in the figure cor-
responds to a hypothetical closed monomer. The T7 helicase 4E fragment (residues 272–566) can be described as an open dimer that contains
a single FU (middle) (Sawaya et al., 1999). The view of the open dimer (middle) is rotated byw90º about the horizontal axis relative to the closed
hexamer (left). Within the crystal, the T7 helicase 4E fragment forms a crystal-wide helical filament (right). 61 symmetry-related subunits along
a single axis are shown. Neighboring filaments related by unit translations are not shown.
(B) a1-antitrypsin cleaved at the P1-P1
0 reactive center peptide bond is a monomer (FU) with the P14-P3 segment inserted into b sheet A (Engh
et al., 1989; Loebermann et al., 1984). During crystallization of a naturally occurring Pittsburgh mutant (M358R) of a1-antitrypsin, the P7-P6
peptide bond is cleaved. A complete FU is formed in the open dimer in which residues P6-P3 form a b strand that is swapped. The addition
of subsequent subunits results in a domain-swapped filament within the crystal (Huntington et al., 1999). Other proteins that form infinite
filaments by domain swapping include ‘‘cab’’-type carbonic anhydrase (Strop et al., 2001), DSAg designer peptide (Ogihara et al., 2001), and
RecA (Story et al., 1992; Xing and Bell, 2004).helicase filament (Figure 3A, right) can be described as
a 1D assembly, like beads on a string, in which subunits
are related by screw symmetry, forming a helical struc-
ture. Each FU is formed by the interactions between
two swapped domains: the ‘‘core’’ domain and an N-ter-
minal helical ‘‘swapped’’ domain (Figure 3A, middle).
Addition of monomers to this open dimer forms a ‘‘run-
away’’-swapped filament in the crystal (Figure 3A, right).
A related construct, called the 4D fragment, which has an
additional 30 residues at its N terminus, forms a closed
hexamer with 6 FUs (Figure 3A, left). The 4E filament isstabilized by the same interdomain interactions as in
the closed 4D hexamer.
Similarly, a1-antitrypsin forms filaments structurally
related to its closed counterpart. a1-antitrypsin is part
of the serpin family, and its function involves cleavage
and insertion of the reactive center loop into a b sheet
(Lomas and Carrell, 2002). The cleaved S variant a1-anti-
trypsin closed monomer (Figure 3B, left) forms after
a proteolysis event at P1-P10 in the reactive center
loop. The filament in Figure 3B (right panel) is formed
from the Pittsburgh variant (M358R) of a1-antitrypsin,
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816which is cleaved at P7-P6 during crystallization and can-
not form a closed monomer (Figure 3B, middle). Thus,
the swap is irreversible. This is reminiscent of proteins
such as staphylococcal nuclease, which irreversibly
converts from a closed monomer to a swapped dimer
after a hinge loop deletion (Green et al., 1995).
The extensive crystal contacts between subunits in
these runaway domain swaps are comparable to those
that stabilize biological homodimers or biologically rele-
vant filamentous structures (Table 1). In general, 3D
domain swapping produces unusually large intersubunit
interfaces due to numerous protein-protein interactions
that evolved in the closed monomer (e.g., RNase A single
swap homodimers). Several groups have found that the
assembly states of proteins in solution (as end-to-end
homodimers) can be inferred from their extensive con-
tact areas in crystals. Ponstingl et al. (2000) found that
85% of proteins could be properly assigned as mono-
mers or dimers solely on the basis of the buried area in
crystal contacts. The threshold cutoff used for assigning
dimers was 1712 A2 (total interface area; i.e., 856 A2 per
subunit) (Ponstingl et al., 2000) (Table 1). Each internal
subunit in a filament has two such interfaces, with the
n21 subunit and the n+1 subunit, which leads to the rel-
atively high overall values for subunits within filaments.
These large intersubunit interfaces do not, however,
imply that domain-swapped filaments will be thermody-
namically stable. This is because domain swapping has
the special feature that the same intersubunit interface
is present in both the filament and the monomer (or small
oligomer), which is not true in systems in which subunits
associate end-to-end. The interface would, however,
stabilize the filament relative to the intermediate open
monomer state, which subunits would necessarily have
to pass through in order to dissociate the filament. That
is, the large interfaces in a domain-swapped filament
would be expected to kinetically trap the subunits once
assembled.
Thermodynamic stability would instead be affected by
other factors, including entropic considerations; addi-
tional interfaces formed in the filament (the ‘‘open’’ inter-
face [Bennett et al., 1995]); different conformations of
hinge loops (reviewed in Rousseau et al., 2003); structural
strains specifically in either the open-ended or closed
form, often in regions near the hinge loops (Dehouck
et al., 2003); and, potentially, by mutations that favor
one or the other form (e.g., hinge loop deletion that pre-
vents a closed monomer from forming). Thus, in some
cases, domain-swapped filaments may be the thermody-
namically favored form. In other cases, they may be meta-
stable and long lived (as in some domain-swapped oligo-
mers such as the diphtheria toxin dimer [Bennett et al.,
1994]).
In general, how do structures observed in crystals re-
late to those found in vivo? A relationship between
crystalline and solution states is established in the litera-
ture on biologically relevant filamentous proteins. For
example, in HbS, the 21 filament observed in crystals
(Wishner et al., 1975) is believed to be a fundamental
component of the fibers associated with sickle cell ane-
mia (Dykes et al., 1978). Protein filaments have also been
observed in crystals of other proteins that form filaments
in vivo (e.g., Rad51 [Conway et al., 2004], RecA [Story
et al., 1992; Xing and Bell, 2004]).Further evidence that domain-swapped filaments can
exist in vivo comes from the serpin family of proteins,
which are involved in human disease. As we have dis-
cussed above and in Figure 3B, the P6-P7-cleaved Pitts-
burgh variant of a1-antitrypsin undergoes irreversible
domain swapping within the crystals. Polymers of
cleaved a1-antitrypsin have also been characterized in
solution by biochemical and ultrastructural techniques,
demonstrating that similar filaments occur in solution
(Mast et al., 1992). In disease states, uncleaved neuro-
serpin and a1-antitrypsin polymerize by a ‘‘loop-sheet’’
mechanism (reviewed in Lomas and Carrell, 2002), which
involves a domain-swapping event that is similar, but not
identical, to that shown in Figure 3B.
The number of structures of crystallized filaments is
relatively small, and smaller still is the subset of such fil-
aments with features of domain swapping. However,
taken together, the examples of infinite linear filaments
Table 1. Domain-Swapped Assemblies Captured in Crystals Have
Extensive Interfaces Comparable to Those in Biological
Assemblies
Protein
Size of Interface
per Subunit (A˚2)
End-to-End Stacks
Threshold for biological homodimers
(Ponstingl et al., 2000)
>856
End-to-end protofilamentsa
Hemoglobin S 2022
Tubulin 2447
3D Domain Swaps
Single swap homodimersb
RNase A N-terminal swap 1992
RNase A C-terminal swap 1835
Single swap filamentsa
T7 helicase 1826
a1-antitrypsin 1775
Double swap aggregatec
TrpR 3500
a The only crystal contacts considered here are those that produce
a protofilament. Further lateral associations in crystals or biological
assemblies are not considered. The area given is the total solvent-
accessible surface area buried per subunit upon going from a mono-
mer (open monomer in the case of domain-swapped associations)
to an internal molecule (as opposed to a terminal molecule) in a fila-
ment. Such an internal molecule has at least two interface contact
regions, one with each of the flanking molecules (HbS has four
contact regions: with two axial and two lateral neighboring mole-
cules). In the case of tubulin, the internal molecule considered is
a b-tubulin monomer flanked by two a-tubulin monomers. Areas
were calculated by using MSMS (Sanner et al., 1996) or CCP4
(CCP4, 1994) and did not include water molecules or ligands in the
calculations. For each contact region, the area buried was divided
by two (to obtain the average area buried per subunit per contact
region); these areas were summed over the total number of contact
regions to obtain the total area buried per subunit in the protofila-
ment. Coordinates used were: 2HBS (Hemoglobin S), 1Z2B (tubulin),
1CR0 (T7 helicase), and 1QMB (a1-antitrypsin).
b The area buried per subunit in going from an open monomer to
a swapped homodimer. Coordinates used were: 1F0V (C-terminal
swap) and 1A2W (N-terminal swap).
c Area buried in going from an open dimer to a swapped molecule in
the crystalline array, based on an area of 875 A˚2/subunit buried
between a single E/F helix domain and the core domain. There are
four such contacts per open dimer in the crystal. Coordinates
used: 1MI7 (trpR).
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817Figure 4. RNase A Q10 Amyloid-like Fibrils Combine Domain Swapping with a Cross-b Spine
(A) Schematics of an open-ended runaway domain swap with a cross-b spine formed by glutamines at the hinge loop (upper panel, side view;
lower panel, top view). Each core domain of RNase A is shown as a cube, and the C-terminal b strand is shown as a triangle. Molecules 1–4 (blue
and magenta) comprise a runaway domain swap with a b sheet formed by their hinge loops (shown as pleated strips). Molecules 5–8 (green and
yellow) form a similar runaway swap and b sheet. The 21 axis is shown in gray.
(B) Proposed model for an RNase A Q10 fibril (upper panel, side view; lower panel, top view; Sambashivan et al., 2005). Packing of side chains be-
tween the two sheets forms the cross-b spine. Specifically, the glutamines in the hinge loops (shown in ball-and-stick) act as a steric zipper that
binds the two sheets together.in crystals illustrate some of the energetic and mechanis-
tic properties that may generally characterize filaments
formed by open-ended runaway 3D domain swapping.
Domain Swapping with a Cross-b Spine
3D domain swapping has also been studied in fibrils of
a model protein, bovine pancreatic RNase A, by bio-
chemical and ultrastructural techniques (Sambashivan
et al., 2005). RNase A provides a favorable model system
for verification of domain swapping in amyloid-like fibrils
in vitro by use of inactive mutants that can reconstitute
activity only when domain swapping occurs. Under cer-
tain conditions, wild-type RNase A undergoes domain
swapping to dimers and trimers whose structures have
been determined by X-ray crystallography (Liu et al.,
1998, 2001, 2002). Wild-type RNase A does not form fi-
brils and is not associated with a deposition disease.
However, a mutant form with a polyglutamine insertion
in its hinge loop (RNase A Q10) forms amyloid-like fibrils
in vitro. These fibrils are both domain swapped and
possess a cross-b spine, as assessed by a combination
of Congo red assays, fiber diffraction, enzyme activity
assays, and electron microscopy (Sambashivan et al.,
2005).
Molecular modeling provides a theoretical structure
that can account for the structural and biochemical prop-
erties of the RNase A Q10 fibrils (Figure 4). In this model,
the hinge loops between swapped domains in RNase A
Q10 are b strands that form two b sheets, which then as-
sociate into a cross-b spine, while peripheral domains
undergo domain swapping (Sambashivan et al., 2005)
(Figure 4). Specifically, monomers 1–4 (colored blueand magenta) form an open-ended runaway swapped fil-
ament (similar to those described in the previous section)
in which the C-terminal b strand of monomer 1 swaps
into the core domain of monomer 2, the C-terminal
b strand of monomer 2 swaps into the core domain of
monomer 3, and so on. The hinge loops form a central
b sheet that packs against an identical b sheet formed
by the other half of the protofilament (monomers 5–8;
colored green and yellow). Thus, the hinge loops form
the cross-b spine, while the peripheral domains are sta-
bilized by runaway domain swapping.
Double Domain Swapping: Different Assemblies
of the Same Protein
In addition to single domain swapping, described in the
sections above, recent structural results have sug-
gested the existence of a phenomenon we term double
domain swapping, which is defined as the simultaneous
exchange of two structural elements. Double domain
swapping provides increased diversity and flexibility in
the types of structures that can be formed from a single
protein, including branched aggregates, which are not
possible with single domain swapping. Such branched
aggregates could account for some nonfibrillar disease
deposits or in vitro aggregates.
The original description of domain swapping assumed
that only a single domain per protein would swap
(Bennett et al., 1995). However, recent studies on bovine
RNase A have revealed that a single protein can swap
more than one domain. The oligomerization of RNase A
has been studied for over 40 years, and it forms
domain-swapped oligomers upon lyophilization from
Structure
818Figure 5. A Single Protein Can Swap More
Than One Domain: The Example of RNase A
(A) A generic protein can be described as
having two terminal domains (N or C termi-
nus) and a core domain (left). Single domain
swapping of the N terminus leads to a closed
dimer, as in the crystal structure of the RNase
A minor dimer (Liu et al., 1998) (top). Single
domain swapping of the C terminus leads to
a different closed dimer, as in the crystal
structure of the RNase A major dimer (Liu
et al., 2001) (bottom). The magenta subunit
is shown in the same orientation in both the
major and minor RNase A dimer structures.
(B) Both domains can be swapped simulata-
neously in RNase A (double domain swap-
ping). Proposed model for the double domain
swapped major trimer that has been charac-
terized biochemically (Liu et al., 2002).acetic acid (Crestfield et al., 1962) or other conditions, in-
cluding increased temperature and concentration (re-
viewed in Libonati and Gotte, 2004). Crystallographic
and biochemical studies have dissected the structures
of dimers (Liu et al., 1998, 2001), trimers (Liu et al.,
2002), and tetramers (Gotte and Libonati, 2004) that
form by domain swapping. These studies have shown
that RNase A is a special example of domain swapping:
it has two ‘‘swappable domains.’’
Crystallographic results demonstrate that RNase A
forms two types of closed dimers that swap either the
N- or C-terminal segment (Liu et al., 1998, 2001) (Fig-
ure 5A). Swapping of the N- or C-terminal domains in
RNase A can be controlled by varying the unfolding con-
ditions. Harsher conditions that lead to greater unfolding
favor the C-terminal swap in simulations and experiments
(Esposito and Daggett, 2005; Gotte et al., 2003).
The ‘‘major trimer’’ of RNase A has been characterized
biochemically and forms a double domain-swapped
structure in which both N- and C-terminal domains are
exchanged (Liu et al., 2002) (Figure 5B). Theoretical
models have been proposed for tetrameric, pentameric,
and hexameric conformers (Gotte et al., 2006; Libonati
and Gotte, 2004) that are believed to similarly involve
double domain swapping.
Double domain swapping has novel features com-
pared to single domain swapping (Figure 6A), including
the potential for avidity and branched morphology. We
define the Swapping Capacity (SC) of a protein as the to-
tal number of partner domains that are required to form
complete FUs from all of its domains.
That is, SC provides an upper limit on the number of
molecules with which a protein of N swappable domains
may interact:
SC = Swapping Capacity = N2 + N: (1)A protein with one swapped domain has the potential to
interact with only two additional neighboring domains
before two complete FUs are formed; therefore, the
protein can only produce a 1D linear arrangement
(Figure 6A, left), which may be open ended or cyclic. In
contrast, a protein with two swappable domains has
the potential to interact with up to six other molecules
to ‘‘satisfy’’ its domains in complete FUs; therefore, the
protein has the potential to form either linear or
branched structures (Figure 6A, right).
Due to the self-complementary nature of domain
swapping, the SC does not, however, predict the number
of molecules with which a given monomer actually inter-
acts. For example, RNase A has two swappable domains
and hence an SC of six. However, in the double swapped
structure of the RNase A major trimer, each monomer
binds only one or two other molecules (Figure 5B). In the-
oretical structures for RNase A pentamers and hexam-
ers, each monomer binds up to three other molecules
(Gotte et al., 2006). In contrast, in the double swapped
E. coli trp repressor (trpR) structure (discussed below),
each dimer interacts with six other dimers, the maximum
predicted by the SC.
Thus, double domain swapping provides a mechanism
for forming different assemblies of the same protein.
Proteins can form both linear filaments and branched ag-
gregates by swapping different domains. The many olig-
omeric forms of RNase A provide evidence of this. For
example, the cyclic RNase A minor trimer can be consid-
ered to be a linear filament that has circularized to satisfy
all of its domains (Liu et al., 2002) (not shown), whereas
the RNase A major trimer is a branched assembly that
has also satisfied all of its domains (Figure 5B).
Aside from expanding the available morphologies of
assembly, another feature of double domain swapping
is that it opens the possibility for multiple binding
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Lead to Branched Aggregates
(A) Single and double domain-swapped
structures have different properties. Open-
ended structures formed by single domain
swapping must always be linear filaments or
cyclic structures, in which each monomer
can bind, at most, two additional molecules
(left). Double domain swapping can lead to
linear or branched aggregates (right). In
double domain swapping, each molecule
can form four interfaces involving up to six
other molecules, leading to potential avidity
effects.
(B) Double domain swapping occurs in trpR
crystallized in aqueous alcohol (Lawson
et al., 2004). The crystal is formed by bona
fide double domain swapping between obli-
gate dimeric subunits (Schevitz et al., 1985).
The boxed FU in the figure corresponds to
this closed-ended dimer. Upon crystallization
in aqueous alcohol, the E/F helix domains are
loosened from the core domain and swapped
with other molecules (Lawson et al., 2004)
(middle and right). Helices E and F of the
magenta and cyan chains form the same
intermolecular bonds as helices E and F of the orange and green chains, respectively, in the closed-ended dimer. Within the crystal, trpR forms
an infinite branched aggregate (right). Symmetry-related subunits within a 35 A˚ radius are shown in gray, and the chains forming a single domain-
swapped FU are colored.interfaces between a single protein monomer and other
subunits that are in a covalently or noncovalently teth-
ered array. This could lead to avidity effects that stabilize
aggregates (see ‘‘Domain Swapping and Avidity’’).
Proteins in general may be capable of swapping more
than one domain. There are now more than 40 examples
of domain-swapped oligomers in which the swapped do-
main is often just an element of secondary structure, such
as a b strand or anahelix (Liu and Eisenberg, 2002). Thus,
even single-domain proteins can be thought of as con-
sisting of a ‘‘core’’ domain and two ‘‘swappable’’ terminal
domains. RNase A, which first revealed this phenome-
non, is arguably the best-studied domain-swapping
protein. As more structures are determined under differ-
ent conditions, double domain swapping may be ob-
served in other proteins. Runaway double domain swap-
ping may account for some aggregates.
Domain Swapping and Avidity
Avidity can result when ‘‘receptors’’ A and B are con-
nected by a linker, resulting in a new molecule, AB,
whose binding affinity for a ligand is given by:
KAB = c ðKAKBÞ; (2)
where KA and KB are the individual affinity (association)
constants, and c is a correction factor that accounts for
the receptors’ linkage, which can be favorable or unfa-
vorable (Jencks, 1981; Mammen et al., 1998). In practice,
linking receptors is often favorable (‘‘the avidity effect’’),
as in tight binding of multivalent Ig receptors to cell-sur-
face ligands or the observation of higher affinities in co-
valent reagents as compared to substituent components
(Shuker et al., 1996). An important feature in avidity is that
both of the receptors must be tethered to one another
and that their ligands must be tethered to one another,
either noncovalently (e.g., by insertion of two receptors
into the same cell surface) or covalently (e.g., by disulfidebonds or peptide bonds). The binding of tethered recep-
tors to their tethered ligands can be thought of as in-
creasing the apparent strength of binding because
both receptors must release from their ligands simulta-
neously for complete dissociation to result. Alternatively,
from the viewpoint of association, avidity can be thought
of as resulting from the increased effective concentra-
tion of the second moiety (receptor B) once the first
moiety (receptor A) is bound.
In domain swapping, the concept of avidity can be ap-
plied by considering the binding of individual domains
rather than that of whole proteins. Thus, an open mono-
mer with one swappable domain (Figure 2A, middle) can
be viewed as a bivalent, covalently tethered reagent in
which a semicircle ‘‘receptor’’ and ‘‘square’’ receptor
are linked by the hinge loop. The release of only one ‘‘re-
ceptor’’ (e.g., the gray semicircle domain) will not result in
dissociation of the homodimer shown in Figure 2A (lower
right).
In an aggregate of the type pictured in Figure 6A (right
panel), avidity will also result. The central black molecule
is connected to its own black domains through covalent
peptide bonds. It binds the aggregate through multiple
noncovalent interdomain interactions. Each of the sur-
rounding gray molecules is similarly tethered within the
aggregate through noncovalent and covalent bonds
(not shown in Figure 6A, right, for clarity). Thus, the re-
lease of the single black semicircle domain from its con-
tact with molecule 4 will not release the central black
molecule from the aggregate. Instead, it remains bound
by virtue of its interactions with molecules 1, 2, and 3.
Also, the release of a single domain will not, in general,
break the aggregate into two smaller aggregates. In con-
trast, the open-ended filament pictured in Figure 6A (left
panel) can be broken in two by releasing only a single
black domain, because molecules 1 and 2 are not teth-
ered to one another.
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avid interactions in cases where molecules are tethered
to one another (for example, in cases where molecules
are inserted at cell surfaces, as in domain swapping
between Ig domains in cadherins [Chen et al., 2005] or
hemolin [Su et al., 1998]).
trpR: An Entirely Domain-Swapped Crystalline Array
The structure of trpR determined in aqueous alcohol
provides insight into the types of aggregated struc-
tures that can be formed by double domain swapping.
Under these conditions, trpR forms an entirely do-
main-swapped, crystal-wide array (Figure 6B) (Lawson
et al., 2004). That is, the crystal itself is a very large,
supramolecular assembly held together by domain
swapping.
The crystal is formed by bona fide double domain
swapping between obligate dimeric subunits, which un-
dergo open-ended swapping of their E/F helix domains
(the green and orange E/F helices in Figure 6B, middle).
Within the crystals, each dimer satisfies its domains by
interacting with six other dimers, the maximum pre-
dicted by the SC. Each trpR dimer is itself a pseudo do-
main-swapped protein that has a highly intertwined
structure but no monomeric homolog (Figure 6B, left).
The FU in the double-swapped crystal consists of one
of these dimers, which has a core domain (helices A, B,
and C of two polypeptide chains) and two swappable do-
mains (helices E/F of each chain). In the presence of
aqueous alcohol during crystallization, the swappable
E/F helix domains are loosened from their core domains,
and a crystalline assembly occurs (Figure 6B, right) in
which each protein dimer binds others by domain swap-
ping. In this process, the D helix region also changes in
conformation, acting as a hinge loop.
Each dimer in the crystal interacts with a total of six
other dimers to form complete FUs from all of its do-
mains. If we focus on the orange/green dimer (Figure 6B,
middle), we see that its core domain (helices A, B, and C
from both chains) binds the E/F helices of the magenta
molecule (first dimer partner) and the E/F helices of the
cyan molecule (second dimer partner) to form a complete
FU (boxed in black). The green E/F helices require a core
domain (third dimer partner; not shown) and another E/F
helix domain (fourth dimer partner; not shown) to make
another complete FU. Similarly, the orange E/F helices
require a core domain and another E/F helix domain to
make the final complete FU (fifth and sixth dimer part-
ners; not shown).
The swapping of trpR dimers also occurs in aqueous
alcohol solution (Lawson et al., 2004). It has been sug-
gested that hydrophobic interactions in the closed dimer
are disrupted under the crystallization conditions used,
and, indeed, domain swapping has also been observed
in other proteins in aqueous alcohol, including cyanovirin
(Yang et al., 1999), cyclophilin 40 (Taylor et al., 2001), and
RNase A (Gotte et al., 2003).
The entirely swapped trpR crystal structure demon-
strates that double domain swapping can lead to ex-
tended branched aggregates. Similar aggregates could
conceivably account for some nonamyloid disease de-
posits, or deposits in vitro, although these would not typ-
ically be crystalline, as in the trpR case.Closed-Ended Domain-Swapped Oligomers
as Building Blocks
Closed-ended 3D domain swapping can also lead
to higher-order assemblies within crystals. That is, do-
main-swapped dimers can stack in an end-to-end man-
ner to form higher-order interactions. This was previ-
ously noted in CD2, in which a deletion mutant forms
a domain-swapped dimer that generates tetramers
within the crystal with an interface of 2000 A2 (Murray
et al., 1998). At least two recent structures have noted
a combination of closed-ended domain swapping and
end-to-end stacking in b-rich assemblies.
End-to-end stacking of swapped homodimers in
a b-rich assembly is illustrated by the structure of N-ter-
minally truncated llama VHH-R9 domain (Spinelli et al.,
2004). In the domain-swapped homodimer, the swapped
domain is the C-terminal strand of an Ig fold, and a new
b sheet of 7 residues is formed at the hinge loop (Fig-
ure 7A). The hinge loop b sheet interacts with edge
b strands from neighboring Ig folds in the crystal, forming
an infinite b structure throughout the crystal (Spinelli
et al., 2004).
In a recent structure of cystatin C, domain-swapped
dimers associate into a crystal-wide assembly (Janow-
ski et al., 2005). The hinge loop in the cystatin C dimer
is flexed relative to other cystatin C structures (compare
Figures 2C and 7B), bringing the b sheets within the di-
mer into a parallel position. Two dimers interact to
make a tetramer (Figure 7B), and packing of the tetra-
mers within the crystal produces an array extending in
three dimensions in which b sheets are all perpendicular
to a common axis. A single continuous filament from this
array is highlighted in Figure 7C (right panel). Thus, the
structure is partially consistent with a cross-b diffraction
pattern, although the intermolecular sheet-sheet pack-
ing expected to produce a 10 A˚ equatorial reflection is
lacking. Cystatin C also associates into tetramers and
octamers in other crystal forms (Janowski et al., 2004),
in part by interactions involving the hinge loop b sheets.
It is not clear as yet how these different assemblies may
be related to disease processes. A stacked filament
structure with aligned b sheets has also been proposed
to account for the amyloid-like fibrils formed from GB1
domain-swapped dimers (Louis et al., 2005).
Implications for Conformational Disease
How relevant are domain-swapped filaments, aggre-
gates, and closed-ended homodimers to conforma-
tional disease? There are now a few biochemical and
biophysical studies that implicate domain swapping in
amyloidosis (e.g., cystatin C [Jaskolski, 2001; Nilsson
et al., 2004; Sanders et al., 2004] and b2-microglobulin
[Eakin et al., 2004]). However, the only direct structural
evidence we have is the observation of closed-ended
domain-swapped homodimers of human PrP and cysta-
tin C in various crystal structures (Figures 2B, 2C, and
7B). Such structures, if they exist in vivo, may undergo
further end-to-end stacking and assembly, as sug-
gested for cystatin C (Janowski et al., 2004, 2005;
Sanders et al., 2004) (e.g., Figure 7C), thus acting as
building blocks in either fibril assembly, or perhaps in
the formation of ‘‘dead-end’’ products. A different model
has been proposed for hamster PrPRDX, in which a run-
away open-ended domain swap forms a cross-b spine
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Can Lead to Higher-Order Aggregates
(A) Llama VHH-R9 domain forms a crystal-
wide b sheet structure by interactions with
the hinge loops (Spinelli et al., 2004).
(B) Cystatin C forms a supramolecular struc-
ture within one crystal form, in which b sheets
are oriented perpendicular to a common axis
(Janowski et al., 2005). Two cystatin C swap-
ped dimers form a tetramer.
(C) Tetramers form b-rich filaments. Here,
a single continuous filament is highlighted.by interaction of hinge loops (Lee and Eisenberg, 2003),
similar to the proposed model for RNase A (Figure 4). It
remains to be determined how, if at all, 3D domain swap-
ping is involved in fibrillization of these proteins in vivo.
We have reviewed here the available structural informa-
tion on higher-order assemblies involving domain swap-
ping, which demonstrate some ways that filamentous or
aggregated structures can be formed, some of which
share features with amyloid or other deposition disease
deposits.
Several structures reveal that 3D domain swapping can
produce novel b strands, which are characteristic of am-
yloid fibrils. Newb sheets are formed at hinge loops in PrP
(Figure 2B), cystatin C (Figures 2C, 7B, and 7C), and llama
VHH-R9 domain (Figure 7A). In the latter two proteins, the
b sheets at hinge loops mediate higher-order interactions
in crystals (Figure 7A and [Janowski et al., 2004; Spinelli
et al., 2004]). The proposed model for the RNase A fibril
also includes a new b sheet formed by the hinge loops,
which creates the cross-b spine at the core of the proto-
filament (Figure 4). To the extent that they are involved
in forming higher-order structures, novel hinge loop
b strands can be considered a type of cryptic epitope
(not present in the normally folded monomer) associated
with increased aggregation or fibrillization.
The conversion of hinge loops to b structures can also
relieve structural ‘‘frustration,’’ which has been pro-
posed to be associated with amyloid fibril formation
from some proteins (Kallberg et al., 2001). Several amy-
loidogenic proteins contain ‘‘frustrated’’ or ‘‘discordant’’
regions in the monomers, where residues do not adopt
the most favored, predicted b strand conformations,but instead form helices (Kallberg et al., 2001). In PrP,
the region in and near the hinge loop in the dimer (Knaus
et al., 2001) is such a frustrated region, and the structural
discordance is relieved in the domain-swapped dimer by
the b strand conformation of the hinge loop (reviewed in
Thirumalai et al., 2003).
Other domain-swapped structures are open-ended fil-
aments, albeit without amyloid cross-b spines (Figure 3).
Nonamyloid fibrils, both swapped and nonswapped, are
known to be involved in some conformational diseases.
These include HbS fibrils in sickle cell anemia, nonamyl-
oid fibrils in some immune cell proliferative diseases,
neuroserpin fibrils involved in encephalopathy, and
a1-antitrypsin fibrils manifesting in systemic disorders
such as cirrhosis and emphysema. Neuroserpin and
a1-antitrypsin are members of the serpin family that
polymerize via a ‘‘loop-sheet’’ mechanism (reviewed in
Lomas and Carrell, 2002), which involves a domain-
swapping event that is similar, but not identical, to that
shown in Figure 3B. Open-ended swapping may also
be combined with a cross-b spine to form amyloid or
amyloid-like fibrils (as in the example of RNase A Q10,
Figure 4).
How might one determine if 3D domain swapping were
involved in fibrils of globular proteins? An essential
feature would be that fibrils would retain elements of
the native structure that could be probed by biophysical
techniques, ligand binding, activity assays, or antibody
binding. For example, DSAg fibrils possess their
native a-helical structure as assessed by FTIR (Ogihara
et al., 2001), and RNase A fibrils reconstitute native
activity from inactive mutants by domain swapping
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could also retain native disulfide bonds, as previously
suggested for hamster PrPRDX (Lee and Eisenberg,
2003). A lack of activity, native disulfides, or native ligand
binding, however, does not prove a lack of domain
swapping. It is possible that these properties could be
disrupted during domain swapping if they involve resi-
dues located in the hinge loop, which changes confor-
mation upon swapping.
Domain swapping is consistent with some characteris-
tic aspects of conformational diseases. Like other mech-
anisms for self-complementation, including the cross-
b spine (Nelson et al., 2005), domain swapping can
account for species barriers and sequence specificity in
prions, because aggregates are held together by
sequence-specific interactions. The ability to form long-
lived metastable species by domain swapping could ex-
plain how two stable conformations (closed monomer
and fibril) can exist for the same globular protein without
violating Anfinsen’s principle (proteins fold spontane-
ously to their native states). We note that recent studies
on suc1 mutants revealed that a metastable monomer is
the initial species formed upon folding at micromolar con-
centrations, even when the domain-swapped dimer is
favored thermodynamically (Kd = nanomolar) (Rousseau
et al., 2004). Could some deposition disease proteins be
metastable monomers thatslowly interconvert to thermo-
dynamically stable swapped fibrils?
Finally, domain swapping could provide a rationale for
the formation of both fibrils and aggregates from an iden-
tical protein in some deposition diseases, if such de-
posits retain native-like structures. The formation of dif-
ferent types of deposits from the same protein can occur
in some lymphoproliferative disorders in which light
chains are overproduced, leading to AL (amyloidosis of
light chains; amyloid fibrils) and LCDD (light chain depo-
sition disease; amorphous aggregates) (Kaplan et al.,
1997; Stokes et al., 1997).
The diversity of domain-swapped structures continues
to increase: from small oligomers to ‘‘infinite’’ filaments
and an entirely domain-swapped crystal. There are now
a number of structures that show that domain swapping
is a common mechanism for conformational switching
in dimers and trimers (Liu and Eisenberg, 2002). The do-
main-swapped aggregates captured in crystals that we
have reviewed here suggest that domain swapping may
be a mechanism for forming more elaborate, larger as-
semblies. When these structures occur in a regulated
way, they may be involved in some biologically relevant
cellular assemblies, such as those formed by cell-surface
binding proteins (e.g., hemolin [Su et al., 1998] and cad-
herin [Chen et al., 2005]). Alternatively, unregulated do-
main swapping may be involved in the formation of aggre-
gates in vitro or in some deposition diseases.
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